切入问题的核心：环氧化酶-2抑制剂、吸烟与心血管风险。 - Suppr

To the heart of the matter: coxibs, smoking, and cardiovascular risk.

作者信息

Hermann Matthias, Krum Henry, Ruschitzka Frank

出版信息

Circulation. 2005 Aug 16;112(7):941-5. doi: 10.1161/CIRCULATIONAHA.105.567842.

DOI:10.1161/CIRCULATIONAHA.105.567842

PMID:16103251

Abstract

摘要

相似文献

To the heart of the matter: coxibs, smoking, and cardiovascular risk.

Circulation. 2005 Aug 16;112(7):941-5. doi: 10.1161/CIRCULATIONAHA.105.567842.

Cyclooxygenase-2 inhibitors and cardiovascular risk.

Curr Opin Cardiol. 2006 Nov;21(6):613-7. doi: 10.1097/01.hco.0000245740.85829.4f.

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Arthritis Rheum. 2006 May;54(5):1378-89. doi: 10.1002/art.21887.

Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.

Ann Med. 2007;39(1):18-27. doi: 10.1080/07853890601073445.

Smoking interacts with sleep apnea to increase cardiovascular risk.

Sleep Med. 2008 Mar;9(3):247-53. doi: 10.1016/j.sleep.2007.03.018. Epub 2007 May 21.

Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.

Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004.

[Cardiovascular risks of selective COX-2-inhibitors].

Dtsch Med Wochenschr. 2004 Dec 3;129(49):2653-6. doi: 10.1055/s-2004-836091.

COX-2 inhibitors and cardiovascular risk.

J Cardiovasc Pharmacol. 2007 Nov;50(5):470-9. doi: 10.1097/FJC.0b013e318157f72d.

Adverse cardiovascular effects of the coxibs.

J Med Chem. 2005 Apr 7;48(7):2251-7. doi: 10.1021/jm0402059.

[Coxibs in treatment and prevention of cancer].

Duodecim. 2005;121(9):929-31.

引用本文的文献

A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital.

Niger Med J. 2014 Sep;55(5):417-22. doi: 10.4103/0300-1652.140386.

Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study.

BMC Cancer. 2012 May 17;12:183. doi: 10.1186/1471-2407-12-183.

Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.

World J Gastroenterol. 2011 Jan 14;17(2):197-206. doi: 10.3748/wjg.v17.i2.197.

Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

BMC Cancer. 2009 Nov 21;9:407. doi: 10.1186/1471-2407-9-407.

Regular use of traditional analgesics predicts major coronary events: A cohort study.

Ther Clin Risk Manag. 2009 Feb;5(1):9-15. Epub 2009 Mar 26.

Cyclooxygenase products and atherosclerosis.

Drug Discov Today Ther Strateg. 2008;5(1):25-36. doi: 10.1016/j.ddstr.2008.05.006.

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

Arthritis Rheum. 2008 Aug 15;59(8):1097-104. doi: 10.1002/art.23911.

Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension.

Curr Hypertens Rep. 2007 Mar;9(1):41-4. doi: 10.1007/s11906-007-0008-4.

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

J Clin Invest. 2006 Jan;116(1):4-15. doi: 10.1172/JCI27291.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

To the heart of the matter: coxibs, smoking, and cardiovascular risk.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献